netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US
No announcement available or all announcement expired.
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US

Board Changes

May 1, 2020
-
News, RNS Announcements

NetScientific plc

(“NetScientific” or the “Company”)

Confirmation of Board Changes

London, UK – 1 May 2020 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, confirms the anticipated management changes announced on 31 March 2020.

 

Ian Postlethwaite resigned from the Board and stepped down as CEO/CFO and Company Secretary on 30 April 2020.

 

At the same time, Dr. Ilian Iliev, previously a Non-Executive Director, was appointed part time Executive Director and interim CEO. Ilian, who also joined the Board of NSCI portfolio company Glycotest, Inc., will continue in his role as MD of EMV Capital, also in a part time capacity.

 

Stephen Crowe, Group Financial Controller since 2018, took over as interim CFO and Company Secretary.

 

Finally, John Clarkson joined the Board of ProAxsis UK limited.

 

John Clarkson, Chairman of NetScientific, said: “I look forward to working with Ilian and Stephen in delivering the requisite proactive management and implementing strategic improvements.”

#  #  #

 

 

  NetScientific

Ilian Iliev, CEO

Tel: +44 (0)20 3514 1800
 
WHIreland (NOMAD, Financial Adviser and Broker)

Chris Fielding / Darshan Patel

Tel: +44 (0)20 7220 1666
 
MO PR ADVISORY (Press Contact)

Mo Noonan

Tel: +44 (0)7876 444977

 

About NetScientific

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.  

 

For more information, please visit the website at www.NetScientific.net

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
PDS Reports Results for Q1 2020 & Business Update
NEXT POST →
PDS expands CRADA with National Cancer Institute

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
Copyright
Terms of Use
Board Changes - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT